Advertisement

Topics

In cost debate, Amgen stands by Repatha's value

04:22 EDT 23 Aug 2017 | BioPharmaDive

New findings from an Amgen-backed study, while more supportive of the drug's value than other analyses, still underscore the challenges posed by the drug's hefty price tag.

Original Article: In cost debate, Amgen stands by Repatha's value

NEXT ARTICLE

More From BioPortfolio on "In cost debate, Amgen stands by Repatha's value"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...